Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Nausea × Calcium Dobesilate × Clear all

Phase

Status

Completed 8 Terminated 5 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 4 Vomiting 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Prostatic Neoplasms 1 Postoperative Nausea and Vomiting 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Nausea 1 Leukemia, Plasma Cell 1 Immunoglobulin Light-chain Amyloidosis 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Dexamethasone 6 Aprepitant 5 Olanzapine 4 Palonosetron 3 Granisetron 2 yangzheng xiaoji 1 stinging nettle lectin 1 ramosetron 1 peppermint oil 1 niraparib 1 netupitant, palosentron drug combination 1 netupitant 1 lerisetron 1 fosaprepitant 1 Whole Body Imaging 1 Tropisetron 1 Transcranial Direct Current Stimulation 1 Tablets 1 Radiotherapy 1 Paclitaxel 1 Ondansetron 1 Music Therapy 1 Metoclopramide 1 Carboplatin 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01913990 2017-01-30

ER11-02

Ottawa Hospital Research Institute

Phase 4 Unknown

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡